Intelligent bio solutions inc. regains compliance with nasdaq minimum bid price requirement and confirms compliance with minimum stockholders' equity requirement

New york, feb. 16, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that on february 13, 2024, it received written notification from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) that the company has regained compliance with nasdaq listing rule 5550(a)(2), which requires that the company's common stock maintain a minimum bid price of $1.00 per share (the “minimum bid price requirement”).
INBS Ratings Summary
INBS Quant Ranking